{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:21:51Z","timestamp":1774876911883,"version":"3.50.1"},"reference-count":29,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Introduction: Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) is a rare autosomal recessive disorder caused by biallelic variants in the tartrate-resistant acid phosphatase 5 (ACP5) and characterized by variable skeletal, immunological, and neurological manifestations. Because early skeletal abnormalities may be subtle, diagnosis can be challenging in infancy. Materials and methods: We conducted a detailed clinical, immunological, radiological, and molecular evaluation of an infant with early-onset cytopenia, recurrent infections, seizures, and developmental delay. Genomic analysis was performed using whole exome sequencing (WES) and copy number variation sequencing (CNV-seq). In addition, we performed a structured narrative review of published ACP5-related SPENCDI cases to summarize the clinical spectrum and the currently reported use of Janus kinase (JAK) inhibitors. Results: Genomic analysis identified an ACP5 stop-gain variant (c.311G&gt;A; p.Trp104*) with an apparently homozygous signal on WES. Re-evaluation of the copy-number data demonstrated an overlapping heterozygous 19p13.2\u2013p13.13 deletion encompassing ACP5, indicating biallelic ACP5 defects consisting of a sequence variant on one allele and deletion of the other allele. Clinically, the patient showed prominent extra-osseous manifestations, including impaired T- and NK-cell cytotoxicity, before the emergence of definite radiographic skeletal abnormalities. Our literature review showed that skeletal abnormalities were repeatedly documented across published ACP5-related SPENCDI reports, although radiographic changes were often subtle and could be preceded by immune manifestations. Reported use of JAK inhibitors suggests potential benefit for immune dysregulation in selected patients, whereas the neurological response remains uncertain. Conclusions: This study reports a novel ACP5 variant and expands the known phenotypic spectrum of SPENCDI. SPENCDI should be considered in children with unexplained immune dysfunction and developmental delay, and suggestive neuroimaging findings, even when overt skeletal deformities are absent. Early genetic testing and targeted skeletal imaging may facilitate diagnosis.<\/jats:p>","DOI":"10.3390\/genes17040390","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:11:59Z","timestamp":1774872719000},"page":"390","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the Genotypic and Phenotypic Spectrum of SPENCDI: A Novel ACP5 Variant and Literature Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-0248","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1200-3842","authenticated-orcid":false,"given":"Jinrong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Decheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100023, China"},{"name":"Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing 100023, China"},{"name":"National Science and Technology Key Infrastructure on Translational Medicine in Peking Union Medical College Hospital, Beijing 100023, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1148\/118.1.133","article-title":"Spondyloenchondrodysplasia. Enchondromatomosis with severe platyspondyly in two brothers","volume":"118","author":"Schorr","year":"1976","journal-title":"Radiology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng0211-90","article-title":"TRAPing a new gene for autoimmunity","volume":"43","author":"Behrens","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/08916930701694667","article-title":"Tartrate-resistant acid phosphatase (TRAP) and the osteoclast\/immune cell dichotomy","volume":"41","author":"Hayman","year":"2008","journal-title":"Autoimmunity"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ajmg.a.31081","article-title":"Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: Clinical and radiographic delineation of a pleiotropic disorder","volume":"140","author":"Renella","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-immunol-020711-074953","article-title":"Monogenic autoimmunity","volume":"30","author":"Cheng","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pbc.26195","article-title":"Childhood-onset autoimmune cytopenia as the presenting feature of biallelic ACP5 mutations","volume":"64","author":"Sacri","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_10","unstructured":"(2022). Medical Laboratories\u2014Requirements for Quality and Competence (Standard No. ISO 15189: 2022)."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_12","first-page":"557","article-title":"Enchondromatosis: Insights on the different subtypes","volume":"3","author":"Pansuriya","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10875-024-01680-2","article-title":"Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCD","volume":"44","author":"Romano","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-015-0035-7","article-title":"Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene","volume":"13","author":"Girschick","year":"2015","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e29672","DOI":"10.1002\/pbc.29672","article-title":"Spondyloenchondrodysplasia with immune dysregulation: Role of sirolimus","volume":"69","author":"Mathiyazhagan","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104286","DOI":"10.1016\/j.ejmg.2021.104286","article-title":"Spondylenchondrodysplasia mimicking a systemic lupus erythematosus: A diagnostic challenge in a pediatric patient","volume":"64","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/rheumatology\/keaa356","article-title":"Successful treatment of spondyloenchondrodysplasia with baricitinib","volume":"60","author":"Shimizu","year":"2021","journal-title":"Rheumatology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, W., Wang, W., Wang, W., Zhong, L., Gou, L., Wang, C., Ma, J., Quan, M., Jian, S., and Tang, X. (2022). Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.825367"},{"key":"ref_19","first-page":"e202303031","article-title":"Spondyloenchondrodysplasia with immune dysregulation related to ACP5. A report of 4 cases","volume":"122","author":"Dri","year":"2024","journal-title":"Arch. Argent. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Gernez, Y., Narula, M., Cepika, A.M., Valdes Camacho, J., Hoyte, E.G., Mouradian, K., Glader, B., Singh, D., Sathi, B., and Rao, L. (2023). Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1\/JAK2 inhibition. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1328005"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/09612033241301506","article-title":"A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus","volume":"34","author":"Ayvaz","year":"2025","journal-title":"Lupus"},{"key":"ref_22","first-page":"e60314","article-title":"Spondyloenchondrodysplasia With Immune Dysregulation, but Without Skeletal Dysplasia, in a Six-Year-Old Boy: A Case Report","volume":"16","author":"Dyab","year":"2024","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00296-020-04653-x","article-title":"Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: Case-based review","volume":"40","author":"Kara","year":"2020","journal-title":"Rheumatol. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3988\/jcn.2019.15.3.407","article-title":"A Case of Familial Spondyloenchondrodysplasia with Immune Dysregulation Masquerading as Moyamoya Syndrome","volume":"15","author":"Lee","year":"2019","journal-title":"J. Clin. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00438-023-02009-1","article-title":"Spondyloenchondrodysplasia in five new patients: Identification of three novel ACP5 variants with variable neurological presentations","volume":"298","author":"Elhossini","year":"2023","journal-title":"Mol. Genet. Genom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00431-025-05982-4","article-title":"Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: A case series study","volume":"184","author":"Oren","year":"2025","journal-title":"Eur. J. Pediatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12519-019-00273-z","article-title":"Toward a better understanding of type I interferonopathies: A brief summary, update and beyond","volume":"16","author":"Yu","year":"2020","journal-title":"World J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","article-title":"Type I interferonopathies: Mendelian type I interferon up-regulation","volume":"32","author":"Crow","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ramesh, J., Parthasarathy, L.K., Janckila, A.J., Begum, F., Murugan, R., Murthy, B., El-Mallakh, R.S., Parthasarathy, R.N., and Venugopal, B. (2020). Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230052"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/4\/390\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:25:07Z","timestamp":1774873507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/4\/390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["genes17040390"],"URL":"https:\/\/doi.org\/10.3390\/genes17040390","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}